Drug/Insect/Latex News

SAN DIEGO — A reimagined approach to uncontrolled severe asthma is needed amid poor diagnosis and management trends, according to Samuel Louie, MD, a professor of medicine at the University of California, Davis.

Only about one-third of patients adhered to their course of maintenance doses in their subcutaneous immunotherapy even when there were no out-of-pocket expenses, according to a study published in Annals of Allergy, Asthma & Immunology.

SAN ANTONIO — Providers can use telemedicine to conduct penicillin and other drug allergy screenings, saving time and costs, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

The Pfizer-BioNTech BNT162b2 COVID-19 vaccine was not associated with any risk for adverse reactions among children with chronic urticaria, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The extra-respiratory symptoms of aspirin-exacerbated respiratory disease improved with omalizumab at baseline and during aspirin challenges, according to a study published in The Journal of Allergy & Clinical Immunology.

SAN ANTONIO — Patients with a history of delayed hypersensitivity to iodinated contrast media exhibited a broad cross-reactivity pattern, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN ANTONIO — An interdisciplinary program increased the number of patients safely desensitized to chemotherapy treatment, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN ANTONIO — A formal curriculum was used to train pediatric residents in de-labeling penicillin allergies in a primary care setting, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Early efficacy in treatment may predict clinical response to subcutaneous immunotherapy for allergic rhinitis due to house dust mite allergy at 3 years, according to a letter published in Clinical and Translational Allergy.

SAN ANTONIO — Day two of the 2023 American Academy of Allergy, Asthma & Immunology Annual Meeting was very busy for new AAAAI president Jonathan A. Bernstein, MD, FAAAAI.